Abstract
Mycobacterium celatum is a recently described slow-growing species. It was identified on the basis of genomic sequencing that differentiates three types. The present report describes two cases ofMycobacterium celatum type I infection in patients with AIDS. Both patients had CD4+ lymphocyte counts of <10/mm3, were receiving rifabutin prophylaxis, and had attended the same treatment units. The minimum inhibitory concentration of rifabutin for both strains was 8 mg/l, which may account for the failure of prophylaxis. As all type 1 strains have the same pulsedfield gel electrophoresis pattern, nosocomial transmission or acquisition from a common source could not be ruled out.
Similar content being viewed by others
References
Butler WR, Steven P, O'Connor SP, Yarkus MA, Smithwick RW, Plikaytis BB, Moss CW, Floyd MM, Woodley CL, Kilburn JO, Vadney FS, Gross WM:Mycobacterium celatum sp. nov. International Journal of Systematic Bacteriology (1993) 43:539–548.
Butler WR, O'Connor SP, Yarkus MA, Gross WM: Cross reactivity of genetic probe for detection ofMycobacterium tuberculosis with newly described speciesMycobacterium celatum. Journal of Clinical Microbiology (1994) 32:536–538.
Bull TJ, Shanson DC, Archard LC, Yates MD, Hamid ME, Minnikin DE: A new group (type 3) ofMycobacterium celatum isolated from AIDS patients in the London area. International Journal of Systematic Bacteriology (1995) 45:861–862.
Piersimoni C, Tortoli E, De Sio G: Disseminated infection due toMycobacterium celatum in patient with AIDS. Lancet (1994) 344:332.
Haase G, Skopnik H, Batge S, Bottger EC: Cervical lymphadenitis caused byMycobacterium celatum. Lancet (1994) 344:1020–1021.
Tortoli E, Piersimoni C, Bacosi D, Bartoloni A, Betti F, Bono L, Burrini C, De Sio G, Lacchini C, Mantella A, Orsi PG, Penati V, Simonetti MT, Bottger EC: Isolation of the newly described speciesMycobacterium celatum from AIDS patients. Journal of Clinical Microbiology (1995) 33:137–140.
Dahl DM, Klein D, Morgentaler A: Penile mass caused by the newly described organismMycobacterium celatum. Urology (1996) 47:266–268.
Piersimoni C, Tortoli E, De Lalla F, Nista D, Donato D, Bornigia S, De Sio G: Isolation ofMycobacterium celatum from patients infected with human immunodeficiency virus. Clinical Infectious Diseases (1997) 24:144–147.
Zurawski CA, Cage GD, Rimland D, Blumberg HM: Pneumonia and bacteremia due toMycobacterium celatum masquerading asMycobacterium xenopi in patients with AIDS: an underdiagnosed problem? Clinical Infectious Diseases (1997) 24:140–143.
David H, Lévy-Frébault V, Thorel MF: Méthodes de laboratoire pour mycobactériologie clinique. Institut Pasteur, Paris (1989) pp. 463–474.
Kirshner P, Springer B, Vogel U, Meier A, Wrede A, Kiekenbeck M, Bange FC, Bottger EC: Genotypic identification of mycobacteria by nucleic acid sequence determination: report of a 2-year experience in a clinical laboratory. Journal of Clinical Microbiology (1993) 31:2882–2889.
Picardeau M, Varnerot A, Rauzier J, Gicquel B, Vincent V:Mycobacterium xenopi IS1395, a novel insertion sequence expanding the IS256 family. Microbiology (1996) 142:2453–2461.
Rastogi N, Bauriaud RM, Bourgoin A, Carbonelle B, Chippaux C, Gevaudan MJ, Seng Goh K, Moinard D, Roos P: French multicenter study involving eight test sites for radiometric determination of 10 antimicrobial agents againstMycobacterium avium complex. Antimicrobial Agents and Chemotherapy (1995) 39:638–644.
Maslo C, Buré-Rossier A, Girard PM, Gholizadeh Y, Lebrette MG, Rozenbaum W: Clinical and bacteriologic impact of rifabutin prophylaxis forMycobacterium avium complex infection in patients with human immunodeficiency virus infection. Clinical Infectious Diseases (1997) 24:344–349.
Picardeau M, Bull TJ, Prod'hom G, Pozniak AL, Shanson DC, Vincent V: Comparison of a new insertion element, IS1407, with established molecular markers for the characterization ofMycobacterium celatum. International Journal of Systematic Bacteriology (1997) 47:640–644.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gholizadeh, Y., Varnerot, A., Maslo, C. et al. Mycobacterium celatum infection in two HIV-infected patients treated prophylactically with rifabutin. Eur. J. Clin. Microbiol. Infect. Dis. 17, 278–281 (1998). https://doi.org/10.1007/BF01699987
Issue Date:
DOI: https://doi.org/10.1007/BF01699987